NMPA Approves China's First Auditory Brainstem Implant
Start here
China's National Medical Products Administration has approved the innovative device registration application for an auditory brainstem implant (ABI) developed by Zhejiang Nurotron Biotechnology. It is the first ABI developed in China and the country's first product to perform electrical stimulation and neural signal extraction in the brainstem region. The approval marks a domestic entry into a device category previously unavailable from Chinese developers, aimed at patients who cannot benefit from cochlear implants. Questions that remain open at this stage include the device's commercial rollout, pricing and reimbursement, and clinical adoption across Chinese hospitals.
Written by a model from the reports · updated 3 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- WeChatPickChina's First Auditory Brainstem Implant Approved by NMPA
China's NMPA has approved the innovative device registration application for the auditory brainstem implant (ABI) from Zhejiang Nurotron Biotechnology. It is the first ABI developed in China and the country's first product to perform electrical stimulation and neural signal extraction in the brainstem region.
Coverage and heat for this story
Reports so far 1·Heat now 9·Peak heat 10 (Oct 20 16:00)·Reports, 24h +1
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.